Rheology and pharmaceutical 3D printing specialist appointed R&D engineer at MB Therapeutics
MB Therapeutics is pleased to welcome Morenikeji Aina as R&D engineer. She brings valuable expertise in rheology applied to complex pharmaceutical systems and innovative processes such as 3D printing of medicines.
A specialist in semi-solid systems and advanced characterization
Trained in pharmaceutical engineering, Morenikeji has specialized in the study of semi-solid formulations and their behavior under processing conditions. Her expertise in pharmaceutical rheology allows her to explore the relationship between the mechanical properties of materials and the performance of drug delivery systems.
These skills are essential for mastering advanced manufacturing technologies such as 3D printing, as well as for optimizing critical parameters like extrudability, stability, and batch-to-batch reproducibility.
From academic research to industrial application
Morenikeji holds a PhD and has conducted recognized research at IMT Mines Albi, focusing on 3D printing of medicines. She is the author of four scientific publications and one review, covering topics ranging from semi-solid rheology to pharmaceutical printing processes. Her work was honored with the Best Poster Award in the Health Engineering section at the 2022 SFGP congress.
Originally from Nigeria, Morenikeji also brings a valuable international dimension to the team. Her fluency in English, which she has spoken since childhood, is a real asset for collaborative projects and the global reach of MB Therapeutics.
Conclusion
The arrival of a new R&D Engineer at MB Therapeutics marks a strategic addition to our ongoing development projects. With a unique profile at the crossroads of applied research and technological innovation, Keji will help advance our expertise in complex processes and pave the way for new generations of personalized drug delivery systems.
Welcome, Keji!
Article references :
